Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BHE | CLS |
|---|---|---|
| Price | $86.11 | $382.69 |
| Change today | ▼ 1.46% | ▼ 1.20% |
| Market cap | $3.09B | $47.71B |
| Return, 3 months | +6.5% | +10.9% |
| Return, year to date | +102.8% | +29.5% |
| Return, 1 year | +125.6% | +62.6% |
| P/E (TTM) | 59.0 | 39.8 |
| P/B | 2.8 | 19.2 |
| P/E percentile vs own 5y | 90th | 78th |
| Dividend yield | 0.79% | – |
| Revenue growth (YoY, latest qtr) | – | +62.4% |
| Net profit growth (YoY) | – | +74.8% |
| Gross margin | – | 12.0% |
| Operating margin | – | 8.8% |
| Net margin | – | 7.2% |
| Return on equity | – | 52.7% |
| Analyst target vs. price | +5.7% | +20.6% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 67 | 63 |
| 30-day volatility | 38.3% | 62.5% |
| Max drawdown, 1 year | -28.8% | -41.2% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
